Aim:
This study aims the investigation of the potential effect of pure curcumin on the inhibition of different enzymes which are involved in several diseases.
Background:
Several chronic diseases such as Alzheimer’s, diabetes, and Parkinson’s disease are related to oxidative stress and enzyme activity. Today, various plant origin products are stated as beneficial against several chronic diseases with secondary metabolites such as phenolic compounds. Curcumin, a polyphenol yellow-orange pigment present in turmeric spices, has a wide range of biological activities, with quite a safety.
Objective:
This study was aimed to investigate the antioxidant and inhibitory potential against key enzymes involved in human pathology, namely Alzheimer's disease (Acetylcholinesterase (AChE), and Butyrylcholinesterase (BChE)), diabetes (α-glucosidase) and hyperpigmentation and Parkinson’s diseases (Tyrosinase) of curcumin.
Methods:
1,1-diphenyl-2-picrylhydrazyl free radical (DPPH●) and hydrogen peroxide radicals (H2O2) assays were used to evaluate the antioxidant capacity of curcumin, enzyme inhibitory activity was evaluated using in vitro standard procedures.
Results:
Curcumin exhibited an excellent antioxidant effect with an IC50 value significantly less than the reference, Vit C. In enzyme inhibitory activity, curcumin demonstrated excellent inhibitory activity against AChE, BChE and α-glucosidase. The finding showed that curcumin was significantly less than the reference galantamine against AChE, but was significantly more than the references galantamine and acarbose against BChE and α-glucosidase, respectively. Whereas for anti-tyrosinase activity, curcumin displayed weak inhibitory activity compared with the standard inhibitor, Kojic acid.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.